📈 Stock #1 - SoFi 📈 Dr. Stock is bullish on SoFi, considering it a fundamental long-term play with potential growth. He's eagerly awaiting Q2 earnings to see if they stay on track to achieve profitability by Q4 2023. Dr. Stock talks about possible price drops in the short term, which could create great buying opportunities for the long term. He also discusses potential resistance levels and trade plays as the stock approaches key price points. 🚗 Stock #2 - Tes...
德纳维制药股票讨论
🗓️ 上周的PDUFAs:
$安进 (AMGN.US)$ : 5/16获批 🎉
⇒ Imdelltra(Tarlatamab-dlle)
‣广泛期小细胞肺癌
‣ PDUFA日期:6/12/24(BLA)
$施贵宝 (BMY.US)$ : 5/15获批 🎉
⇒ Breyanzi®
• 滤泡性淋巴瘤
‣ PDUFA日期:5/23/24(sBLAs)
$德纳维制药 (DVAX.US)$ : CRL 5/14 🙁
⚠️ 数据不足
⇒ Heplisav-B
‣ 透析成年人接种疫苗
‣ PDUFA日期:5/13/24(sBLA)
$Ascendis Pharma A/S (ASND.US)$ : 审查延长至8/14/24 🤔
⇒ YORV...
Dynavax: Crl表示申请未提供足够的数据来支持对Heplisav-B 4剂量方案的有效性或安全性进行全面评估
📣 5月即将到来的4个 PDUFAs:
$德纳维制药 (DVAX.US)$ : 🤔
⇒ Heplisav-B
‣ 透析成年人接种疫苗
‣ PDUFA日期:5/13/24(sBLA)
$Ascendis Pharma A/S (ASND.US)$ : 🤔
⇒ YORVIPATH®
‣ 假性甲状旁腺功能减退症
‣ PDUFA日期:5/14/24 (新药申请)
$施贵宝 (BMY.US)$ : 🤔
⇒ Breyanzi®
‣ PDUFA日期:(sBLA)
‣‣ 5/23/24 (复发/复发滤泡性淋巴瘤)
‣‣ 5/31/24 (复发/复发套细胞淋巴瘤)
🗓️ 上周的 PDUFAs:
$X4制药 (XFOR.US)$ 批准日期为4/29 🎉
⇨ XOLREMDI (mavorixafor)
‣ WHI...
$辉瑞 (PFE.US)$ $德纳维制药 (DVAX.US)$ $沙尘暴黄金 (SAND.US)$ $施贵宝 (BMY.US)$ $SPDR标普生物科技ETF (XBI.US)$
Dr. Stock is bullish on SoFi, considering it a fundamental long-term play with potential growth. He's eagerly awaiting Q2 earnings to see if they stay on track to achieve profitability by Q4 2023. Dr. Stock talks about possible price drops in the short term, which could create great buying opportunities for the long term. He also discusses potential resistance levels and trade plays as the stock approaches key price points.
🚗 Stock #2 - Tes...
为了分析这些股票, 股票博士使用moomoo, 这是一个平台, 你可以从描述中使用他的链接获得高达17支免费股票, 包括可能的CE三的一支免费股票。他直接进行了分析, 从股票EOG开始。他解释说, EOG目前低于移动平均线, 表明看淡的趋势和潜在的下行风险。对于那些对看跌期权或开空感兴趣的人来说, EOG可能是一个合适的股票。
如果您不熟悉期权,还有其他方式可以参与波动交易。然而,需要注意的是c3.ai的期权费用可能相对较高,使得认购和认沽变得更加昂贵。尽管如此,如果您对该股票的潜力有信心,考虑一下也许是值得的。
暂无评论